Semaglutide and other newer GLP-1 medications have proven to be far more effective at treating obesity than diet and exercise, and their benefits seem to extend beyond just weight loss
[1] [2] Marketed under brand names including Ozempic, Wegovy, and Rybelsus, semaglutide works by mimicking the incretin hormone GLP-1, which enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways
[160] showed that high/increased flavonoids (e.g., myricetin) intake is associated with lower lung cancer risk in their studied population (meta-analysis of 8 prospective studies and 4 case-control studies involving 5073 lung cancer cases and 237,981 non-cases)
Patients with poorly controlled diabetes may have increased infection susceptibility and should maintain heightened vigilance
Quartarone G
This can be a symptom of fluid retention that can lead to or worsen heart failure